Testing effectiveness (Phase 2)Study completedNCT02301611What this trial is testingPhase IIB TL + YCWP + DC in MelanomaWho this might be right forMelanoma Elios Therapeutics, LLC 187
Early research (Phase 1)Ended earlyNCT01744171What this trial is testingVaccine Therapy in Treating Patients With Advanced Stage III-IV MelanomaWho this might be right forRecurrent MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT01294735What this trial is testingStudy of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)Who this might be right forRecurrence of Solid TumorGlioblastoma MultiformeMelanoma Merck Sharp & Dohme LLC 19
Early research (Phase 1)Ended earlyNCT05573035What this trial is testingInvestigate LYL845 in Adults With Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerColorectal Cancer Lyell Immunopharma, Inc. 39
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Not applicableStudy completedNCT01898403What this trial is testingLymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant MelanomaWho this might be right forRecurrent Melanoma Stanford University 50
Testing effectiveness (Phase 2)Study completedNCT07671495What this trial is testingAdjuvant Therapy of Skin Melanoma With Alpha Interferon and NaderinWho this might be right forMelanoma Stage IMelanoma Stage IIIMelanoma Stage II+1 more MIPO Clinic 278
Testing effectiveness (Phase 2)Study completedNCT00466687What this trial is testingErlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma Vanderbilt-Ingram Cancer Center 34
Not applicableUnknownNCT00450593What this trial is testingIdentifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary MelanomaWho this might be right forHereditary Multiple MelanomaMelanoma (Skin) Leeds Cancer Centre at St. James's University Hospital 5,000
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Study completedNCT00074230What this trial is testingVaccine Therapy in Treating Patients With Stage IV Cutaneous MelanomaWho this might be right forMelanoma (Skin) University Hospital Erlangen 82
Testing effectiveness (Phase 2)WithdrawnNCT02263898What this trial is testingIntermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 MutationsWho this might be right forRecurrent MelanomaStage IV Melanoma Jonsson Comprehensive Cancer Center
Not applicableUnknownNCT06073548What this trial is testingPatient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method StudyWho this might be right forUveal Melanoma Institut Curie 250
Early research (Phase 1)Active Not RecruitingNCT04483778What this trial is testingB7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsWho this might be right forPediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more Seattle Children's Hospital 68
Not applicableStudy completedNCT01886235What this trial is testingIntravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by SurgeryWho this might be right forRecurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more Roswell Park Cancer Institute 10
Early research (Phase 1)Ended earlyNCT03727789What this trial is testingCBL0137 in Treating Patients With Advanced Extremity Melanoma or SarcomaWho this might be right forAdvanced Cutaneous Melanoma of the ExtremityAdvanced Sarcoma of the ExtremityClinical Stage III Cutaneous Melanoma AJCC v8+10 more Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT00026221What this trial is testingBevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant MelanomaWho this might be right forRecurrent MelanomaStage IV Skin Melanoma National Cancer Institute (NCI) 57
Early research (Phase 1)Study completedNCT00658892What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma (Skin) Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00104897What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant MelanomaWho this might be right forMelanoma (Skin) Cancer Research UK 25
Testing effectiveness (Phase 2)Study completedNCT00021164What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI)